Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $860.77 | 55 | 90.0% |
| Education | $95.52 | 2 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $217.51 | 15 | $0 (2024) |
| ABBVIE INC. | $148.79 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $85.00 | 1 | $0 (2018) |
| Novo Nordisk Inc | $80.39 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $53.12 | 4 | $0 (2023) |
| Abbott Laboratories | $51.15 | 3 | $0 (2022) |
| Mission Pharmacal Company | $44.01 | 3 | $0 (2018) |
| PFIZER INC. | $38.14 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $35.14 | 2 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $30.36 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $191.43 | 10 | ABBVIE INC. ($87.87) |
| 2023 | $145.68 | 8 | AbbVie Inc. ($38.40) |
| 2022 | $43.37 | 2 | ABBVIE INC. ($22.52) |
| 2021 | $42.29 | 3 | Abbott Laboratories ($30.30) |
| 2020 | $118.73 | 8 | AstraZeneca Pharmaceuticals LP ($43.87) |
| 2019 | $46.31 | 3 | Shire North American Group Inc ($16.29) |
| 2018 | $205.77 | 11 | Astellas Pharma US Inc ($85.00) |
| 2017 | $162.71 | 12 | AstraZeneca Pharmaceuticals LP ($33.53) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Respiratory | ||||||
| 10/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: VACCINES | ||||||
| 06/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Obesity | ||||||
| 06/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Cardio-renal | ||||||
| 06/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 04/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Endocrinology | ||||||
| 05/05/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes Care | ||||||
| 02/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes Care | ||||||
| 08/17/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes Care | ||||||
| 03/17/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Respiratory | ||||||
| 11/18/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,170 | 6,349 | $444,938 | $226,501 |
| 2022 | 36 | 3,078 | 5,721 | $448,674 | $226,580 |
| 2021 | 39 | 3,099 | 6,064 | $400,442 | $214,786 |
| 2020 | 43 | 3,290 | 6,800 | $388,232 | $198,318 |
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 754 | $118,310 | $54,778 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 424 | 869 | $91,992 | $43,490 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 378 | 378 | $63,580 | $42,849 | 67.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 208 | 209 | $18,079 | $14,209 | 78.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 75 | $15,837 | $8,874 | 56.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 133 | 179 | $12,351 | $8,730 | 70.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 42 | $12,075 | $7,843 | 65.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $7,150 | $7,007 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 209 | 210 | $7,350 | $5,944 | 80.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 30 | 30 | $3,750 | $3,675 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 155 | 424 | $13,085 | $3,286 | 25.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $4,730 | $2,907 | 61.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 73 | 81 | $5,589 | $2,804 | 50.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 41 | 45 | $4,554 | $2,560 | 56.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 32 | 51 | $11,202 | $1,614 | 14.4% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 129 | 206 | $3,105 | $1,507 | 48.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 25 | 55 | $3,352 | $1,458 | 43.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 32 | 41 | $3,237 | $1,456 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 54 | 54 | $1,520 | $1,390 | 91.4% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 25 | 41 | $7,685 | $1,258 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 39 | $2,915 | $1,169 | 40.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 149 | 1,497 | $7,485 | $1,044 | 14.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 35 | $1,575 | $793.36 | 50.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 15 | 16 | $1,218 | $757.22 | 62.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 72 | 81 | $7,638 | $707.87 | 9.3% |
About Dr. Richard Cole, MD
Dr. Richard Cole, MD is a Family Medicine healthcare provider based in Tullahoma, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578558441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cole, MD has received a total of $956.29 in payments from pharmaceutical and medical device companies, with $191.43 received in 2024. These payments were reported across 57 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($860.77).
As a Medicare-enrolled provider, Cole has provided services to 12,637 Medicare beneficiaries, totaling 24,934 services with total Medicare billing of $866,185. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Tullahoma, TN
- Active Since 09/15/2005
- Last Updated 05/27/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578558441
Products in Payments
- FARXIGA (Drug) $148.26
- UBRELVY (Drug) $71.95
- VRAYLAR (Drug) $53.00
- Binosto (Drug) $44.01
- AIRSUPRA (Drug) $37.82
- Ozempic (Drug) $35.49
- BREZTRI (Drug) $31.43
- Kerendia (Drug) $30.36
- FreeStyle Libre 2 (Device) $30.30
- JARDIANCE (Drug) $27.69
- TROKENDI XR (Drug) $25.12
- QULIPTA (Drug) $23.84
- FREESTYLE LIBRE 2 (Device) $20.85
- INVOKANA (Drug) $20.48
- Vascepa (Drug) $18.87
- Cologuard Collection Kit (Device) $16.36
- NATPARA (PARATHYROID HORMONE) (Drug) $16.29
- TRELEGY ELLIPTA (Drug) $16.24
- SHINGRIX (Biological) $15.98
- LYRICA (Drug) $15.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tullahoma
Dr. John Patsimas, Md, MD
Family Medicine — Payments: $21,344
Dr. Brett Ferrell, M.d, M.D
Family Medicine — Payments: $15,148
Dr. John Anderson, M.d, M.D
Family Medicine — Payments: $7,189
Dr. Barry Cortis, D.o, D.O
Family Medicine — Payments: $961.43
Dr. Thomas Phelps, Md, MD
Family Medicine — Payments: $598.25
Alison Horrocks, Fnp-C, FNP-C
Family Medicine — Payments: $473.20